Standard BioTools(LAB) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Standard BioTools Reports Third Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif., October 30, 2024 -- Standard BioTools Inc. (NASDAQ: LAB) (the "Company") today announced unaudited interim financial results for the third quarter ended September 30, 2024. Recent Highlights: • Reported third quarter 2024 revenue of $45 million • Ongoing merger cost synergy realization delivered 50% adjusted EBITDA improvement and 35% net loss improvement year-over-year • Operationalized approximately $8 ...